Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?

M. S. Wijsenbeek, F. Bonella, L. Orsatti, A. M. Russell, C. Valenzuela, W. A. Wuyts, W. F. Baile

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
5 Downloads (Pure)


Communications between clinicians and patients with idiopathic pulmonary fibrosis (IPF) have the potential to be challenging. The variable course and poor prognosis of IPF complicate discussions around life expectancy but should not prevent clinicians from having meaningful conversations about patients’ fears and needs, while acknowledging uncertainties. Patients want information about the course of their disease and management options, but the provision of information needs to be individualised to the needs and preferences of the patient. Communication from clinicians should be empathetic and take account of the patient’s perceptions and concerns. Models, tools and protocols are available that can help clinicians to improve their interactions with patients. In this article, we consider the difficulties inherent in discussions with patients with IPF and their loved ones, and how clinicians might communicate with patients more effectively, from breaking the news about the diagnosis to providing support throughout the course of the disease.

Original languageEnglish
Article number00422-2021
JournalERJ Open Research
Issue number1
Early online date24 Jan 2022
Publication statusPublished - 2022

Bibliographical note

Funding Information:
Acknowledgements: The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for development of this article. Writing assistance was provided by Wendy Morris of FleishmanHillard, London, UK, which was contracted and funded by Boehringer Ingelheim. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as well as intellectual property considerations. The page processing charges for this article would be funded by Boehringer Ingelheim.

Publisher Copyright:
© The authors 2022.


Dive into the research topics of 'Communicating with patients with idiopathic pulmonary fibrosis: can we do it better?'. Together they form a unique fingerprint.

Cite this